Challenges to the Chinese health insurance system: users' and service providers' perspectives.

In different jurisdictions, acceptance of new drugs are based on different willingness-to-pay thresholds expressed as currency per quality-adjusted life years gained, such as $50,000 in the US,[ 22 ] and approximately ≤30,000 in the UK.[ 23 ] The recommendations from the WHO of three time the per capita GDP in developing countries[ 24 ] was used for the Chinese PE guidelines.[ 24 25 ] Although there is an increasing trend of more PE publications in China that indicates its popularity in academia,[ 26 ] there is still a need to have legislation to promote HTA/PE evaluations in China.

also in 63,971 other papers